Joseph Marakovits

1.6k total citations
12 papers, 1.0k citations indexed

About

Joseph Marakovits is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joseph Marakovits has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joseph Marakovits's work include Viral Infections and Immunology Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Signaling Pathways in Disease (3 papers). Joseph Marakovits is often cited by papers focused on Viral Infections and Immunology Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Signaling Pathways in Disease (3 papers). Joseph Marakovits collaborates with scholars based in United States. Joseph Marakovits's co-authors include Rose Ann Ferre, Chuangxing Guo, Brion W. Murray, Eleanor Dagostino, David A. Matthews, Eugenia Kraynov, Amy K. Patick, Ru Zhou, Stephen T. Worland and James W. Meador and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Joseph Marakovits

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Marakovits United States 10 657 349 202 177 168 12 1.0k
Miroslav Malešević Germany 19 742 1.1× 157 0.4× 125 0.6× 182 1.0× 109 0.6× 49 1.1k
Jinzhi Tan China 15 684 1.0× 105 0.3× 151 0.7× 376 2.1× 193 1.1× 25 1.1k
Richard H. Ingraham United States 23 723 1.1× 153 0.4× 225 1.1× 348 2.0× 129 0.8× 34 1.7k
T.C. Appleby United States 22 775 1.2× 162 0.5× 121 0.6× 361 2.0× 276 1.6× 29 1.5k
Amartya Basu United States 23 457 0.7× 165 0.5× 71 0.4× 172 1.0× 439 2.6× 40 1.2k
J.K. Muckelbauer United States 12 261 0.4× 130 0.4× 339 1.7× 187 1.1× 135 0.8× 17 738
Tsu‐An Hsu Taiwan 16 398 0.6× 70 0.2× 159 0.8× 125 0.7× 200 1.2× 28 804
Mark Ammirati United States 14 598 0.9× 169 0.5× 54 0.3× 61 0.3× 173 1.0× 20 1.2k
Paola Lo Surdo Italy 19 1.2k 1.9× 308 0.9× 38 0.2× 115 0.6× 141 0.8× 38 1.9k
Naoyuki G. Saito United States 13 583 0.9× 239 0.7× 26 0.1× 155 0.9× 110 0.7× 32 1.0k

Countries citing papers authored by Joseph Marakovits

Since Specialization
Citations

This map shows the geographic impact of Joseph Marakovits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Marakovits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Marakovits more than expected).

Fields of papers citing papers by Joseph Marakovits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Marakovits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Marakovits. The network helps show where Joseph Marakovits may publish in the future.

Co-authorship network of co-authors of Joseph Marakovits

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Marakovits. A scholar is included among the top collaborators of Joseph Marakovits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Marakovits. Joseph Marakovits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Holleran, John P., Shweta Sharma, Angelina M. Santini, et al.. (2024). Abstract 2083: Discovery of ETX-19477, a novel and selective PARG inhibitor with high potency against tumors with underlying replication stress. Cancer Research. 84(6_Supplement). 2083–2083. 5 indexed citations
2.
Guo, Chuangxing, Xinjun Hou, Liming Dong, et al.. (2014). Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket. Bioorganic & Medicinal Chemistry Letters. 24(17). 4187–4191. 38 indexed citations
3.
Guo, Chuangxing, Liming Dong, Joseph Marakovits, & Susan E. Kephart. (2011). A novel method to enable SNAr reaction of aminopyrrolopyrazoles. Tetrahedron Letters. 52(14). 1692–1696. 1 indexed citations
4.
Murray, Brion W., Chuangxing Guo, Joseph Piraino, et al.. (2010). Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proceedings of the National Academy of Sciences. 107(20). 9446–9451. 253 indexed citations
5.
Dong, Liming, Joseph Marakovits, Xinjun Hou, et al.. (2010). Structure-based design of novel human Pin1 inhibitors (II). Bioorganic & Medicinal Chemistry Letters. 20(7). 2210–2214. 70 indexed citations
6.
Guo, Chuangxing, Xinjun Hou, Liming Dong, et al.. (2009). Structure-based design of novel human Pin1 inhibitors (I). Bioorganic & Medicinal Chemistry Letters. 19(19). 5613–5616. 91 indexed citations
7.
Skalitzky, Donald J., Joseph Marakovits, Karen A. Maegley, et al.. (2002). Tricyclic Benzimidazoles as Potent Poly(ADP-ribose) Polymerase-1 Inhibitors. Journal of Medicinal Chemistry. 46(2). 210–213. 126 indexed citations
8.
Webber, Stephen E., Joseph Marakovits, Peter S. Dragovich, et al.. (2001). Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(20). 2683–2686. 10 indexed citations
9.
Borch, Richard F., et al.. (2000). Synthesis and Evaluation of Nitroheterocyclic Phosphoramidates as Hypoxia-Selective Alkylating Agents. Journal of Medicinal Chemistry. 43(11). 2258–2265. 45 indexed citations
10.
Dragovich, Peter S., Stephen E. Webber, Thomas J. Prins, et al.. (1999). Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. Bioorganic & Medicinal Chemistry Letters. 9(15). 2189–2194. 18 indexed citations
11.
Matthews, David A., Peter S. Dragovich, S. E. Webber, et al.. (1999). Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proceedings of the National Academy of Sciences. 96(20). 11000–11007. 243 indexed citations
12.
Dragovich, Peter S., Thomas J. Prins, Ru Zhou, et al.. (1999). Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l-Glutamine Replacements. Journal of Medicinal Chemistry. 42(7). 1213–1224. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026